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Abstract
Background: Excessive exposure to dietary fats is an important factor in the initiation of obesity and metabolic syndrome
associated pathologies. The cellular processes associated with the onset and progression of diet-induced metabolic
syndrome are insufficiently understood.
Principal Findings: To identify the mechanisms underlying the pathological changes associated with short and long-term
exposure to excess dietary fat, hepatic gene expression of ApoE3Leiden mice fed chow and two types of high-fat (HF) diets
was monitored using microarrays during a 16-week period. A functional characterization of 1663 HF-responsive genes
reveals perturbations in lipid, cholesterol and oxidative metabolism, immune and inflammatory responses and stress-related
pathways. The major changes in gene expression take place during the early (day 3) and late (week 12) phases of HF
feeding. This is also associated with characteristic opposite regulation of many HF-affected pathways between these two
phases. The most prominent switch occurs in the expression of inflammatory/immune pathways (early activation, late
repression) and lipogenic/adipogenic pathways (early repression, late activation). Transcriptional network analysis identifies
NF-kB, NEMO, Akt, PPARc and SREBP1 as the key controllers of these processes and suggests that direct regulatory
interactions between these factors may govern the transition from early (stressed, inflammatory) to late (pathological,
steatotic) hepatic adaptation to HF feeding. This transition observed by hepatic gene expression analysis is confirmed by
expression of inflammatory proteins in plasma and the late increase in hepatic triglyceride content. In addition, the genes
most predictive of fat accumulation in liver during 16-week high-fat feeding period are uncovered by regression analysis of
hepatic gene expression and triglyceride levels.
Conclusions: The transition from an inflammatory to a steatotic transcriptional program, possibly driven by the reciprocal
activation of NF-kB and PPARc regulators, emerges as the principal signature of the hepatic adaptation to excess dietary fat.
These findings may be of essential interest for devising new strategies aiming to prevent the progression of high-fat diet
induced pathologies.
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Introduction
Pathologies associated with metabolic syndrome, such as
overweight and obesity, insulin resistance, hypertension, hyperlip-
idemia, non-alcoholic hepatic steatosis and diabetes are becoming
a health problem of epidemic proportions in Western societies [1–
3]. In addition to genetic factors, diet represents the most
important determinant of the development and progression of
the metabolic syndrome [4]. High-fat diets have been shown to
induce obesity and insulin resistance in humans and rodents [5–7].
It is believed that short-term high-fat feeding triggers a stress
response (termed ‘‘metabolic stress’’), which challenges the system
to adapt to the new conditions and maintain homeostasis. If the fat
overload persists, the system fails to adjust and consequently
undergoes pathophysiological changes characteristic for metabolic
syndrome [8,9]. The early diagnostics of metabolic stress and the
elucidation of the molecular mechanisms underlying a transition
from the early to late stages of metabolic syndrome are of crucial
importance for developing intervention strategies for preventing
irreversible disease characteristics.
It is generally acknowledged that excessive exposure to dietary
lipids disrupts the homeostasis of cellular metabolism and triggers
an inflammatory response in adipose tissue [10]. Nevertheless, the
dynamics and coordinate regulation of processes perturbed by
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6646
excess dietary fat in other organs is scarcely understood. Several
recent studies highlighted the important role of lipid-activated
nuclear receptors such as peroxisome-proliferator-activated recep-
tors (PPARs) in the integration of metabolic and inflammatory
processes [11]. In addition to their role as transcription activators
of metabolic genes, PPARs are receiving an increasing attention as
inhibitors of inflammatory gene expression achieved primarily
through suppression of the pro-inflammatory NF-kB pathway
[11,12]. This dual function makes PPARs attractive targets for
intervention in both metabolic and inflammatory disorders,
although little is known about role of PPARs in the diseases
where the cross-talk of these pathways may be fundamental to the
development of pathogenesis [13–15]. Despite the significant
progress in the field, much work is still required to fully understand
the molecular mechanisms underlying the effects of high-fat diets
and delineate their coordination during onset and progression of
metabolic syndrome on organ and systems level.
In this study, we have used Apolipoprotein E3-Leiden (ApoE3L)
mice to investigate the effect of two types of standard laboratory
high-fat (HF) diets on development of metabolic syndrome.
ApoE3L transgenic mice are an established model for studying
the effect of dietary interventions on hyperlipidemia, atheroscle-
rosis and other diet-related pathologies [16–23]. Due to the
expression of the human APOE*3Leiden and apoC1 gene cluster
in C57BL/6J (B6) background, the ApoE3L mice display a
lipoprotein profile that closely resembles that of humans, and they
develop human-like dysbetalipoproteinemia and atherosclerotic
lesions when fed Western-type diets [24,25]. We show that
ApoE3L mice fed either a beef tallow- or palm oil- based high-fat
diet (HFBT and HFP, respectively) for 16 weeks develop metabolic
syndrome characteristics, such as obesity and hepatic steatosis. By
monitoring the genome-wide hepatic mRNA expression of these
mice at eight time-points, covering the period from the beginning
of the high-fat feeding until the occurrence of significant changes
in metabolic syndrome parameters (week 16), we could construct a
comprehensive view of the biological processes characteristic of
hepatic adaptation to excess dietary fat during the progression
from metabolic stress to metabolic syndrome. The reciprocal
activation of the inflammatory/immune response and the
lipogenic/adipogenic pathways emerges as the most prominent
signature of the transition from short to long-term HF feeding and
underscores the relevance of the antagonistic action of NF-kB and
PPARc regulators in controlling the shift from the stressed,
inflamed to the pathological, steatotic hepatic state. These results
provide novel insights into the interaction between metabolic and
inflammatory processes during the development of metabolic
syndrome that may be important when considering strategies to
prevent and treat the disease.
Results
To investigate the processes associated with the high-fat (HF)
induced metabolic stress and the progression of the metabolic
syndrome, male ApoE3L mice were fed one of the three standard
laboratory diets: chow (control diet), HFBT (45 energy %, beef
tallow high-fat diet containing 0.25% cholesterol) and HFP (45
energy % palm oil high-fat diet), for a period of 16 weeks
(Materials and methods). The primary aim of the study was to
identify the effects of excessive dietary fat content and to determine
how these effects change over time. The additional aspect that we
aimed to address was to which extent parameters other than
percentage of fat determine the consequences of HF feeding.
Dietary parameters, such as fat origin or presence or absence of
cholesterol, may also be relevant determinants of HF diet effects.
To address this aspect, cholesterol-containing animal fat-based
diet (HFBT, also referred to as Western-type diet) and plant oil-
based diet with relatively high amount of saturated fats (HFP) were
investigated in parallel. During the 16 week experimental period
the body weight of both HFBT and HFP fed mice increased
significantly compared to the chow-fed mice (Figure 1A).
To focus on the molecular mechanisms underlying the
development of metabolic syndrome, hepatic mRNA expression
of HF- and chow-fed ApoE3L mice (n = 150) was monitored using
DNA microarrays over a period of 16 weeks. At the day 0 and
eight additional time-points (day 1, day 3, week 1, 2, 4, 8, 12 and
16) mice were sacrificed, their livers were sampled and the RNA
expression was analysed using NuGO Affymetrix mouse arrays
[26]. After the quality control and the preprocessing of data,
expression values were obtained for 15105 genes in 3 to 6
biological replicate samples per diet and time-point (Materials and
methods).
Global temporal changes in hepatic transcriptome
during the 16-week time-course
To assess temporal changes in hepatic gene expression over the
16-week period under the control and two high-fat diets, each of
the time points per diet was compared to time-point day 0 in a
pairwise fashion using limma statistical package [27]. Applying
statistical cutoff of false discovery rate (FDR) ,0.1, we identified
839, 3027 and 3316 genes differentially expressed by chow, HFBT
and HFP feeding, respectively, across any of eight time-points
(Figure S1). This showed that ageing of animals from 14 weeks (at
the beginning of the experiment) to 30 weeks (at its end) affected
expression of a portion of genes, also in the control condition.
Nevertheless, the combined effects of ageing and high-fat feeding
observed in HFBT and HFP conditions was substantially larger
compared to solely aging effects.
In addition to overall temporal effects, comparing each of the
time points to day 0 allowed assessment of dynamics of transcrip-
tional response by detecting the magnitude of the gene expression
changes at each time point compared to the starting condition. In
both HF conditions we observed three phases of hepatic
transcriptional response characterized by local peaks in the
number of differentially expressed genes: early (day 1 to week 1),
mid (week 2 and week 4) and late (week 8 to week 16) (Figure S1).
In addition to the phasic trend, the number of differentially
expressed genes in HF conditions increased gradually during the
course of the experiment. This may be expected considering that
using day 0 as a common reference leads to combined contri-
bution of both high-fat intervention and ageing to the observed
effects. In chow condition, temporal trends identified for HF diets
were absent and the numbers of changed genes in each of the
time-points remained below the ones identified in HF conditions
(Figure S1).
Hepatic transcription response to high-fat diets
After determination of the temporal effects of all three diets
across 16-week time-course, we focused on dissecting the HF-
specific effects on the hepatic transcriptome. To analyse the effects
of HF diets independently of changes occurring due to the animal
age, we compared the gene expression of mice fed HFBT and
HFP diets to those of mice fed the chow diet in each of the
corresponding time-points. The pairwise comparisons were
performed using the limma statistical package, and FDR q-
value,0.1 was used as a threshold for significance. The numbers
of identified differentially expressed genes in each diet and time-
point are shown in Table 1 and Table S1. Per time-point, the
number of up- and down-reglated genes was largely balanced, and
Hepatic Effects of HF Diets
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Figure 1. Increased body weight and gene expression changes induced by HFBT and HFP high-fat diets. (A) Average body weight of
ApoE3L mice fed either chow, HFBT or HFP diet in each time point of the 16-week time course. Error bars represent standard deviation within a
group. Statistically significant (p,0.05) increase in body weight of HFBT and HFP fed mice compared to chow fed mice are marked with asterisk and
hash sign, respectively. (B) Overlap between the total numbers of statistically significant differentially expressed genes in livers of ApoE3L mice fed
either HFBT or HFP diet compared to chow diet per time-point, over the 16-week time-course. (C) Hierarchical clustering (Pearson correlation,
complete linkage) of 16 experimental conditions (two high-fat diets at 8 time-points) and 1663 genes differentially expressed under either of two
high-fat conditions. Values used for clustering are average HFBT vs. chow and HFP vs. chow per time-point expression ratios. The branches of the
condition tree are colored so to discriminate three subclusters with the largest distance, corresponding to three phases of the time-course: early (red),
mid (orange) and late (yellow). This is summarized in the color bar underneath the cluster diagram. The lower color bar indicates distinct time-points,
stressing the similarity of HFBT and HFP transcriptional response at each point of the time-course.
doi:10.1371/journal.pone.0006646.g001
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genes changed expression in the same direction in both HF
conditions (Table S1). In total, during the 16-week time-course the
HFBT diet significantly affected the expression of 1263 genes,
while HFP diet affected 836 genes (8.3% and 5.5% of the
monitored genome, respectively). The statistically significant
differentially expressed genes (DEG) under the two HF diets
largely overlap (436 genes, p-value 1.7E-265) (Figure 1B).
To compare gene expression patterns of identified HFBT and
HFP DEGs across all conditions, expression profiles of genes that
are changing in either of HF diets compared to chow diet per
time-point (1663 genes in total) were hierarchically clustered
(Figure 1C). The close proximity of condition tree branches
corresponding to two diets in each of the time-points revealed a
striking similarity between the effects of HFBT and HFP diets on
the expression of all 1663 genes. Therefore, not only 436
overlapping genes, but also the remaining genes unique to each
condition changed similarly under the HFBT and HFP diets,
although they did not pass significance threshold in both
conditions. Due to this highly comparable gene expression
response, the union of differentially expressed genes under the
HFBT and HFP diets was further considered as a total set of 1663
HF-responsive genes (Table S1, Table S2). This set of HF-
responsive genes was used for all downstream functional analyses
that required a limited set of genes of interest as input.
Nevertheless, to be able to assess subtle differences between the
effects of two HF diets caused by different fat origin and/or the
presence or absence of cholesterol in a diet, gene expression
changes are always displayed separately for each of two diets.
Three distinct phases (early, mid and late) of hepatic
transcriptional response to HF diets were observed by comparing
each time-point to day 0 (Figure S1). These phases are also
revealed by hierarchical clustering of the experimental conditions
in Figure 1C, where gene expression of mice fed HFBT and HFP
diets was compared to those of mice fed the chow diet at each of
the corresponding time-points. To further characterize the
expression profiles of the 1663 HF-responsive genes, Smoothing
Spline Clustering was performed [28] (Figure S2, S3, S4 and S5).
The identified gene expression profiles typically show peaks at
early (day 3), mid (week 2) and/or late (week 8/12) phase of the
time-course. Especially prominent expression changes were
observed at the early and the late phase, as determined by the
intensity of the gene expression changes and the abundance of the
significant differentially expressed genes (Table 1, Figure 1C,
Table S1, Table S2). Interestingly, many genes change the
direction of their regulation between the early and the late phase
of the time-course (Figure 1C, Figure S2, Figure S3, Figure S4 and
Figure S5). Similarly to the observation obtained by comparing
each time-point to day 0, the peak-intervening time-points are
characterized by a more modest transcription response and may
reflect resumptions of the local homeostasis resulting from the
transient adaptation to excess dietary fat.
To identify which cellular processes are most affected by the
hepatic exposure to excess dietary fat over the entire time-course,
we first analyzed the overrepresented functional categories among
the 1663 HF-responsive genes [29]. The most prominent
significantly enriched functional clusters are related to lipid,
cholesterol and oxido-reductive metabolism, as well as inflamma-
tion, immune response, apoptosis, cell cycle, protein folding and
the regulatory pathways controlling these processes (Figure 2,
Table S3 (‘‘All HF-responsive genes’’)). The expression changes
per diet and time-point of the selected representative genes for
each functional cluster are also shown in Figure 2. To assess if
some of the categories are specifically enriched in either up- or
down-regulated genes, we additionally performed the equivalent
type of analysis using separately lists of HF-responsive up- and
downregulated genes (Table S3 (‘‘Upregulated HF-responsive
genes’’ and ‘‘Downregulated HF-responsive genes’’)). As a number
of genes changed the direction of their regulation between the
early and the late phase of the time-course, many categories were
represented in both lists. Specifically, the enrichment of lipid
metabolism and inflammatory processes were highly significant
among the upregulated HF-responsive genes, and glutathione
metabolism and cholesterol biosynthesis were most significant
among the downregulated HF-responsive genes.
Integrative temporal and functional characterization of
the hepatic transcription response to high-fat diets
To include prior biological knowledge in pathway analysis, both
public and proprietary gene sets were used for Gene Set
Enrichment Analysis (GSEA) [30] of each of the HFBT and
HFP versus chow per time-point comparisons. In addition, to
facilitate the dynamic interpretation of the identified biological
functions, statistically significant GSEA results were hierarchically
clustered across all conditions, thus integrating temporal and
functional information into single visual output (Materials and
methods). Hierarchical clustering of the GSEA-calculated nor-
malized enrichment scores (NES) resulted in an aggregation of the
similarly regulated gene sets, facilitating the visualization of
Table 1. Number of statistically significant differentially expressed genes per time-point (FDR q-value,0.1).
Time point HFBT vs. chow HFP vs. chow
Overlap (HFBT vs. chow)
and (HFP vs. chow)
Day 1 0 0 0
Day 3 550 416 193
Week 1 88 82 31
Week 2 317 136 76
Week 4 33 44 9
Week 8 7 209 2
Week 12 521 144 85
Week 16 23 52 7
All time-points 1263 836 436
Total (both diets, all time-points) 1663
doi:10.1371/journal.pone.0006646.t001
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Figure 2. Functional characterization of the high-fat responsive genes. Representative overrepresented functional categories in the set of
1663 high-fat responsive genes are grouped according to their biological function: (a) lipid and cholesterol metabolism, (b) oxidative and metabolic
processes, (c) inflammatory and immune response, (d) apoptosis and protein folding, (e) cell growth and cell cycle and (f) transcription regulation and
signal transduction. For each functional group, representative genes are listed and their expression profiles (average HFBT vs. chow and HFP vs. chow
expression ratios per time-point) are shown in the adjacent diagrams.
doi:10.1371/journal.pone.0006646.g002
Hepatic Effects of HF Diets
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pathway activities during the 16-week response to HF diets. The
resulting cluster of 314 gene sets, significant (FDR q-value,0.1) in
at least one of the HF conditions, can be visually divided into five
temporal modules (Figure 3).
An examination of the cluster heatmap reveals that the vast
majority of the gene sets change the direction of their
transcriptional regulation throughout the time-course. The first
and largest module contains gene sets that are generally
significantly upregulated during the early phase (day 3) and
downregulated at the late phase of the HF-response (week 8, 12
and/or 16). The most characteristic gene sets in the module 1 are
associated with inflammation and immune response and their
regulation, such as Interleukin (IL)-1, IL-2, IL-3, IL-4, IL-5, IL-7
and IL-9 pathways, CD40 pathway, antigen processing and
presentation, T and B cell receptors signaling, natural killer (NK)
cell cytotoxicity, leukocyte migration and Tumor necrosis factor
(TNFalpha), Nuclear factor-kappa B (NF-kB) and Toll-like
Receptor (TLR) signaling pathways. The second representative
functional theme in module 1 is related to cell growth,
proliferation and differentiation. Examples of these gene-sets
include cyclins and cell cycle regulators, G1 to S and G2 to M
checkpoint controllers, DNA replication reactome and Mitogen-
activated protein (MAP) kinases, Epidermal growth factor (EGF)
and Transforming growth factor beta (TGF-b) signaling pathways.
Additionally, various gene sets related to cancer and development
also follow the early induction/late repression expression pattern.
In contrast to module 1, gene sets in the last module (5) are
generally repressed during the early phase and significantly
upregulated during mid and late phases. The most prominent
functional characteristic of module 5 is the presence of the PPAR
signaling pathway as well as many PPARs-regulated gene sets,
including those associated with adipocytes differentiation (IDX_T-
SA_UP_CLUSTER6, ADIP_VS_FIBRO_UP, ADIP_DIFF_UP,
NADLER_OBESITY_DN), fatty acid oxidation and lipogenesis.
The transcriptional activation of these gene sets during the mid
phase and their amplification during the late phase implies an
important role for PPARs in regulating the transition from short- to
long-term effects of hepatic exposure to excess dietary fat.
Additionally, hepatic activation of the genes involved in adipocytes
differentiation and lipogenesis suggests that fat accumulation and
adipogenic transformation likely take place in the liver after long-
term exposure to a high-fat diet. Other aspects of the metabolic
control, such as amino acid metabolism and tricarboxylic acid cycle,
are also upregulated during mid and late phases of the HF-response.
Despite the large overall similarity in transcription response to
HFBT and HFP diets, a comparison of pathway activities reveals
specific differences between the two high-fat conditions. This is
particularly evident in the gene sets clustered in the lowest part of
the module 3. Notably, the regulation of gene sets involved in
energy metabolism (glycolysis and gluconeogenesis, oxidative
phosphorylation, pentose phosphate pathway, electron transport
chain) is sensitive to variations in fat origin and/or specific
compositions of HF diets. Specifically, a palm oil-based HF diet
(HFP) causes a transient induction of the gene sets involved in
energy metabolism at day 1 but shows attenuated induction of
these gene sets in the late phase compared to a beef tallow-based
HF diet (HFBT). Similar deviation in the gene set activity patterns
between HFP and HFBT conditions is also visible in the module 5.
Finally, a small fraction of all the represented gene sets retains a
constant transcriptional pattern throughout the time-course. These
are represented in modules 2 (constantly downregulated gene sets,
e.g. cholesterol biosynthesis, glutathione metabolism and metab-
olism of xenobiotics by cytochrome P450) and module 4
(constantly upregulated gene sets, such as lipoprotein metabolism).
The reciprocal transcriptional profiles of the pathways repre-
sented in modules 1 and 5 emerge as the principal signature of the
transition from early to late hepatic transcription response to
excess dietary fat. The coincidence of the repression of
inflammatory, immune and cell proliferation pathways and the
induction of metabolic, lipogenic and adipogenic pathways
prompted the hypothesis that these events may be interdependent
and their swap relevant for driving the transition from a stressed to
pathological hepatic state. The relationships between inflamma-
tory and metabolic processes and the key regulators controlling
them were further investigated using biological network analysis.
Network analysis of the HF-responsive genes: interplay
between PPARc and NF-kB regulatory modules
To further explore the control of and the biological connectivity
between the HF-responsive genes, the set of 1663 genes (Figure 1B,
1C, Table S1, Table S2) was used as an input for the network
analysis within the Ingenuity Pathway Analysis suite [31]. The
networks with the highest significance score (network score equal
to or higher than 35) and their associated biological functions are
listed in the Table 2. To focus on the interactions between the
processes identified as crucial for the transition from early to late
hepatic response to excess dietary fat, networks related to immune
response, lipid metabolism and hepatic steatosis (networks 1, 2 and
4) were merged for further examination (Figure 4, 5). The network
number was limited to three to restrict the size and facilitate the
clarity of the resulting network.
The analysis identified several major regulators of the cellular
response to high-fat diets appearing as the hubs in the resulting
network: PPARc, SREBF1 and SREBF2 - regulators of lipid, fatty
acid and cholesterol metabolism, NF-kB – regulator of immune
response and Akt – regulator of cell growth, proliferation and
differentiation. Aside from the constant transcriptional shutdown
of the SREBF2 local subnetwork that regulates cholesterol
biosynthesis, the majority of network components show a
characteristic swap in transcription response between early (day
3) and late (week 12) phase of the time-course (Figure 4, 5).
To further investigate relations between the network compo-
nents that show the observed swap in transcription response and to
characterize their associated functions in more detail, we
examined ‘‘Function and disease’’ categories that are overrepre-
sented in the network. By overlaying the most significant
categories over the network, the categories ‘‘hepatic steatosis’’ (p-
value 1.41E-08) and ‘‘immune response’’ (p-value 5.85E-07) were
identified as the best representatives of processes that are
reciprocally regulated during the early and the late phase of
high-fat response. In addition to the largely reciprocal regulation,
these processes are interconnected via few key network compo-
nents (pink lines, Figure 4, 5). The gene expression of nearly all the
network components involved in the promotion of inflammation
and immune response is induced during the early phase and
repressed during the late phase of the HF response, including NF-
kB regulatory factors, interferon, cytokine and chemokine
signaling molecules, acute phase response reactants and comple-
ment components. In contrast, network members promoting
development of hepatic steatosis, such as PPARc, SCD, SREBF1,
ACOX1, CIDEC and CFD (adipsin) are repressed during early
phase and induced during the late phase of hepatic response to HF
diets. The exception to the observed global repression of
inflammatory and immune response in the late phase are
interleukin-1 pathway components and, somewhat, the acute
phase reactants that show statistically insignificant, low-grade re-
induction at week 12 and week 8, respectively. This indicates that
a modest fraction of the inflammatory response, likely mediated by
Hepatic Effects of HF Diets
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Figure 3. Temporal modules of pathway activities during the hepatic high-fat response. Hierarchical clustering (Pearson correlation
(uncentered), average linkage) of Normalized Enrichment Scores (NES), as determined by Gene Set Enrichment Analysis. The NES values of 314 gene
sets, significant (FDR q-value,0.1) in at least one of HFBT vs. chow and HFP vs. chow per time-point comparisons are used as an input for hierarchical
clustering. The NES scores, represented by the color gradient, correspond to the relative up- (red) and down- (blue) regulation of the gene sets under
each of experimental conditions. The cluster diagram can be divided into five main temporal themes (depicted as modules 1 to 5), highlighting the
main trends in temporal pathway activities: (1) early activation/late repression; (2) constant repression; (4) constant activation and (5) early repression/
mid and late activation. Module (3) includes fuzzy pathway profiles that bring to light differences in transcription response to beef tallow- (HFBT) and
palm oil-based (HFP) high-fat diets.
doi:10.1371/journal.pone.0006646.g003
Hepatic Effects of HF Diets
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JNK/AP-1 pathway parallel to NF-kB signaling escapes the global
repression [32,33].
Particularly interesting are the network members that are
associated with both inflammatory and steatotic transcriptional
modules, namely PPARc and IKBKG (inhibitor of kappaB kinase
gamma). It has been previously shown that PPARc antagonizes
inflammatory responses by a transrepression of NF-kB regulators
and that its hepatic activation leads to the development of liver
steatosis [11,12,34–38]. In contrast, IKBKG, also known as NF-
kB essential modulator (NEMO), is required for the activation of
the NF-kB complex by proinflammatory stimuli, and it has
recently been recognized as suppressor of hepatic steatosis,
possibly through the negative interaction with PPARs [39–42].
The gene expression data show significant repression of PPARc
during the early phase of the high-fat response. In contrast, at the
mid and/or late phases, PPARc and its target genes are induced,
while NEMO is simultaneously significantly repressed (Figure 6,
Table S2). This reciprocal transcriptional activity proposes an
appealing model where the direct trans-repression between
PPARc and NEMO/NF-kB regulators may occur, controlling
the transition from early to late hepatic response to HF diets.
Evidently, further biochemical studies are required to confirm the
suggested temporal transrepression.
Transition from hepatic inflammation to steatosis is
reflected by inflammatory plasma proteins and hepatic
triglyceride levels
The transition from an inflammatory (early) to steatotic (late)
transcriptional program in livers of ApoE3L mice observed by
gene expression profiling is supported by expression of plasma
proteins and liver triglyceride content. A series of inflammatory
plasma proteins were quantified by multiplex immunoassay during
the complete high-fat feeding time-course (Materials and meth-
ods). The transient activation of many inflammation-related
proteins has been observed during the early phase of the time-
course (data not shown). The levels of plasma proteins likely reflect
a systems response of multiple organs to excess dietary fat.
Nevertheless, the trend of early activation coupled with late
repression, which has been observed in the expression of many
hepatic inflammatory genes when HF diets are compared to chow
diet, can also be found in the expression of NF-kB-related plasma
inflammatory proteins. Examples of such proteins are NF-kB
activating protein Immunoglobulin A (Figure 7A) and NF-kB
activated proteins Beta-2 Microglobulin, Interleukin-18 and
Macrophage-Derived Chemokine (CCL22) (Figure 7B-D) [43–
47]. The upregulation of Interleukin-18 at week 4 and week 8
under all three dietary conditions is followed by HF-specific
repression at the two last time-points (Figure 7C).
The activation of the steatotic transcriptional program during
the late phase of the high-fat feeding time-course observed by
transcriptome analysis harmonizes with the increased hepatic
triglyceride content at the late time-points (Figure 8A). To identify
genes whose expression is most predictive of hepatic fat
accumulation under high-fat dietary conditions, liver triglyceride
content and expression of 1663 high-fat responsive genes in each
animal were used to perform regression analysis by random forest
modeling [48,49]. The genes with highest importance in the
resulting model (n = 30) are shown in Figure 8B. The genes we
identified as steatosis-associated by the network analysis (Figure 4,
Figure 5), such as ACOX1, SCD, PPARc, CFD and CIDEC were re-
discovered by the regression analysis. Also, matrix metallopepti-
dase 13 (MMP13) implicated in liver fibrosis and ENTPD5,
associated with hepatopathy and hepatocellular tumors were
identified by the regression approach [50,51]. In addition to the
known markers of hepatic pathology, random forest modeling
uncovered putative novel candidate genes whose expression may
predict the development of hepatic steatosis. This includes fatty
acid metabolism associated genes (CRAT, ACAA1b and ACAT),
matrix endopeptidase related proteins (ITIH5, MME) and several
genes of unknown function. The gene identified as the best
predictor of hepatic steatosis by the regression analysis, butyr-
ylcholinesterase (BCHE) has been mostly studied in the context of
its effect on the brain’s cholinergic system [52]. However, there is
evidence showing that serum butyrylcholinesterase is associated
with adiposity, serum lipid profile and insulin resistance in humans
[53]. Therefore, BCHE may be the potential marker of interest for
further investigation of the hepatosteatosis development.
Together, inflammatory plasma proteome and hepatic triglyc-
eride content support findings obtained by mRNA expression
analysis, further substantiating the proposed shift between the
hepatic inflammatory and steatotic transcriptional program during
prolonged exposure to high-fat diets.
Discussion
Hepatic pathophysiological changes induced by short-
and long-term exposure to excess dietary fat
In this study, we focused on investigating the molecular
mechanisms underlying the onset and progression of the metabolic
syndrome during a 16-week high-fat feeding time-course in
ApoE3L transgenic mice. The changes in hepatic transcriptome
revealed that the adaptation to excess dietary fat proceeds in three
phases: early, mid and late. The early (day 1 to week 1) and the
Table 2. Top scoring networks among the high-fat responsive genes (Ingenuity Pathway Analysis).
Network number Score* Focus Genes** Top Functions
1 40 33 Immune Response, Tissue Development, Skeletal and Muscular System Development and
Function
2 40 33 Cellular Development, Connective Tissue Development and Function, Lipid Metabolism
3 37 32 Protein Synthesis, Genetic Disorder, Neurological Disease
4 35 31 Hepatic System Disease, Liver Steatosis, Cancer
5 35 31 Endocrine System Development and Function, Lipid Metabolism, Small Molecule
Biochemistry
*Score is the negative exponent of the p-value representing the likelihood that the network eligible molecules that are part of a network are found therein by random
chance alone.
**Focus Genes is the number of network eligible genes from the input list represented in the network.
doi:10.1371/journal.pone.0006646.t002
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late (week 8 to week 16) phases are characterized by the most
prominent, and often reciprocal peaks in gene expression changes.
During the early phase, the initial sensing of the fat overload
triggers the cellular stress response, characterized by activation of
acute phase reactants, inflammatory and immune response
(Figure 2, 3, 4). The deregulation of the cell cycle and certain
apoptotic genes during the early phase of high fat feeding resemble
hepatic regeneration response, further suggesting compromised
liver integrity. Additionally, the immediate perturbation occurs in
mitochondrial, microsomal and peroxisomal oxido-reductive
processes, including the severe repression of specific members of
cytochrome P450 family and glutathione transferase genes
(Figure 2, 3, Table S2). The imbalance in oxido-reductive
processes accompanied with a diminished protective function of
glutathione transferases may create conditions of elevated liver
sensitivity to oxidative damage [54]. The hypersensitivity to
oxidative stress could synergize with the lipotoxic stress, manifest-
ed by the activation of unfolded protein response (UPR),
endoplasmatic reticulum (ER) stress and DNA damage response
(Figure 2, 3). Apart from the stress response, the early phase of the
hepatic transcriptional response to high-fat diets is also character-
ized by metabolic adaptation. Of all the pathways involved in lipid
metabolism, early activation is exclusively observed in lipid/
lipoprotein binding and transport (Figure 2, 3). This suggests that
Figure 4. Molecular network underlying hepatic response to high-fat diets (day 3). The global molecular associations of the high-fat
responsive genes are functionally characterized and divided into networks based on the functions and/or diseases that are most significant to the
network objects (Ingenuity Pathway Analysis). Depicted is the result of merging the network 1 (Immune Response, Tissue Development, Skeletal and
Muscular System Development and Function), network 2 (Cellular Development, Connective Tissue Development and Function, Lipid Metabolism)
and network 4 (Hepatic System Disease, Liver Steatosis, Cancer). The overrepresented ‘‘Function and disease’’ (Fx) categories ‘‘immune response’’ and
‘‘hepatic steatosis’’ are overlaid onto resulting network, showing which genes (nodes) are directly involved in these processes. The interactions
between nodes that are directly connected to both processes are highlighted in pink. Color coding of the nodes corresponds to the direction of gene
expression changes at day 3 in HFBT vs. chow diet comparison (upregulated genes are shown in red and downregulated in green).
doi:10.1371/journal.pone.0006646.g004
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the primary, short-term metabolic adjustment may involve hepatic
elimination of fatty acid surplus by means of its excretion in the
form of very low-density lipoprotein (VLDL) particles. Cholesterol
efflux and biliary secretion are also immediately activated, coupled
with repression of cholesterol biosynthesis (Figure 2, 3).
The major signature of the late phase of the hepatic adaptation
to excess dietary fat is the transcriptional induction of nearly all
aspects of lipid metabolism, including those regulated by PPARa
(lipolysis, fatty acid beta-oxidation), PPARc (adipogenesis and
adipogenic transformation, lipogenesis, lipid accumulation, lipid
uptake) and SREBP1 (lipogenesis, fatty acid synthesis, fatty acid
desaturation, fatty acid elongation) (Figure 2, 3, 5). The need for
long-term lipid management is, thus, likely resolved by an
activation of both lipolysis and hepatic lipid storage. The pro-
steatotic transcriptional program, manifested in the activation of
lipogenic, adipogenic and lipid accumulation pathways and the
activation of genes such as PPARc gene itself, stearoyl-CoA
desaturase 1 (SCD1) and CIDEC (Fsp27) (Figure 2, 3, 5, 6) suggest
that the adipogenic transformation of hepatocytes and the
development of liver steatosis may occur during the late phase of
HF feeding [34–37,55]. This finding is supported by the increase
of total hepatic triglycerides in the late phase of the time-course
and their significantly elevated levels at the week 16 in mice fed
HF diets compared to chow fed mice (Figure 8A). The incidence of
hepatic steatosis under the similar experimental conditions has also
been reported in the literature [21,35]. The regression analysis of
association between hepatic gene expression and the lipid
accumulation identified known and novel genes that may be
valuable as predictors of hepatosteatosis development.
The observed hepatic adaptation to excess dietary fat occurs
similarly in investigated beef tallow- (HFBT) and palm oil- fat
(HFP) based diets. Nevertheless, specific differences in the gene
expression response to these two diets do exist. This is particularly
evident in the expression of pathways related to energy
Figure 5. Molecular network underlying hepatic response to high-fat diets (week 12). The equivalent network to that in Figure 4, except
that the color coding of the nodes corresponds to the direction of gene expression changes at week 12 in HFBT vs. chow diet comparison.
doi:10.1371/journal.pone.0006646.g005
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metabolism during the early and the long-term adaptation to high-
fat feeding. In general, mice fed HFP diet show more pronounced
transient induction of these pathways at the very beginning of the
time course, but fail to activate them as efficiently as the mice fed
HFBT diet at the late phase of the time-course (Figure 3). These
differences in processes that are relevant for energy expenditure
may account for a higher increase in body weight (Figure 1A) and
significantly higher whole-body insulin resistance (data not shown)
of HFP-fed mice compared to HFBT-fed mice at the end of the
time-course. This observation may be relevant in the context of
dietary recommendations, suggesting that the excess of palm oil-fat
based diet may be at least as harmful, if not more so, than the
cholesterol-containing beef tallow fat-based diet.
The hypothesized mechanism controlling the switch
from an inflammatory to steatotic hepatic state during
the high-fat feeding response
The majority of pathways affected by the high-fat diets exhibit
opposite regulation during the early and the late phase of the high-fat
feeding time-course. This synchronous swap of the major functional
signatures between the early and the late phase and the fact that the
key controllers of the reciprocally regulated processes (as revealed by
the network analysis (Figure 4, Figure 5)) are implicated in the mutual
repression suggest that the regulatory exchange may occur via tightly
controlled reactions, limited to few master regulators.
The NF-kB and Akt regulators, the key controllers of the
pathways showing early activation/late repression expression
mode (i.e. inflammation, immune response, cell proliferation and
cell differentiation), have been previously reported to act
synergistically [56–59]. Similarly, PPARc and SREBP1, identified
in our study as the key regulators of pathways in the early
repression/late activation transcriptional module are co-acting in
regulating lipid metabolism and adipogenesis [60,61]. In contrast
to the synergistic activities within these transcriptional modules,
there is emerging evidence of the antagonistic activity between
them, particularly regarding NF-kB and PPAR regulators. There
is limited evidence for the NF-kB mediated repression of PPARc
[62]. In turn, multiple mechanisms by which PPARs inhibit
inflammatory gene expression through interference with NF-kB
signaling have been reported (reviewed in [11,15,63]). Several
studies investigated the inhibitory effect of PPARc and its agonists
on the activity of the inhibitor of nuclear factor kB kinase (IKK)
complex [64–66]. The IKBKG (NF-kB essential modulator,
NEMO) is the subunit of the IKK complex indispensable for the
activation of NF-kB [42]. Considering its critical role, we propose
the model in which down-regulation of NEMO in the mid and the
late phases of HF response could be the most important regulatory
event controlling the shut-down of NF-kB driven inflammatory
response at the switch point between stressed and pathological
hepatic state. In addition to NEMO, other two IKK related genes
(IKBKE, IKBKAP) and the gene coding for NF-kB subunit RelB
also show characteristic early induction and late repression
transcription mode (Figure 6, Table S2). The coincident opposite
transcriptional activity of PPARc and its target pathways suggests
that the two regulatory events may be interdependent (Figure 6).
This hypothesis is supported by the recent studies showing that
NEMO has an essential physiological role in preventing the
spontaneous development of hepatic steatosis preceding hepato-
cellular carcinoma and that the hepatic ablation of NEMO in mice
fed HF diet increases PPARc mRNA levels and aggravates hepatic
steatosis [39,40]. The suggested mechanism of the mutual
repression of PPAR and NEMO/NF-kB regulators during their
coordination of the transition from early to the late phase of HF-
response remains to be confirmed by biochemical studies.
The relevance of the proposed model of the transition
from high-fat induced metabolic stress to metabolic
syndrome in ApoE3L mice
The dynamic functional landscape of the hepatic transcriptional
adaptation to excess dietary fat during the 16-week time-course
suggests a model in which sequential physiological changes underlie
the transition from metabolic stress to metabolic syndrome,
Figure 6. Reciprocal activation of regulators of an inflammatory and steatotic transcriptional programs during high-fat feeding
time-course. The average gene expression profiles of NF-kB regulators (RelB, IKBKG, IKBKE, IKBKAP) (red line) and PPARc/hepatic steatosis-associated
genes (PPARc, SREBF1, SCD1, ACOX1, CIDEC, CFD) (yellow line) during the 16-week high-fat feeding time-course. (A) HFBT vs. chow diet. (B) HFP vs.
chow diet.
doi:10.1371/journal.pone.0006646.g006
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summarized in Figure 9. These results provide novel insight into the
delicate cross-talk between inflammation and lipid metabolism in
controlling the progression of metabolic disease development. It is
Figure 7. Expression changes of plasma proteins caused by
HFBT and HFP high-fat diets. Expression changes of a subset of
inflammatory plasma proteins that show trend of early activation
coupled with late repression compared to the control condition during
the 16-week high-fat (HF) feeding time-course, as measured by
multiplex immunoassay. Plotted are average protein expression levels
per time point in mice fed chow, HFBT and HFP diets. Statistically
significant changes in protein expression of HFBT and HFP fed mice
compared to chow fed mice per time-point are marked with asterisk
and hash symbol, respectively (p value,0.05). All four proteins are
associated with NF-kB activation. (A) Immunoglobulin A, protein that
activates NF-kB. (B–D) Beta-2 microglobulin, Interleukin-18 and
Macrophage-derived chemokine (CCL22), proteins activated by NF-kB.
doi:10.1371/journal.pone.0006646.g007
Figure 8. Regression analysis of gene expression and hepatic
triglyceride content in chow and high-fat-fed ApoE3L mice. (A)
Changes in hepatic triglyceride (TG) content induced by HFBT and HFP
high-fat diets and a control (chow) diet during the 16-week time course.
Plotted are average values of hepatic triglyceride levels per time point
in each of the three diets. Statistically significant increase (p#0.01) in
hepatic TG content of HFBT and HFP fed mice compared to chow fed
mice (marked with asterisk and hash symbol, respectively) was
observed at the time-point 16 weeks, indicating development of
hepatic steatosis. (B) The most important genes for the prediction of
hepatic triglyceride levels, as assessed by Random Forests Regression
analysis. The expression of 1663 high-fat responsive genes and the
hepatic triglyceride levels in each animal were used as an input for the
regression analysis. The plot shows the importance of the top 30 genes
in the Random Forest regression model. The importance of a gene in
the model is expressed as the increase of Mean Squared Error (MSE)
when the gene is excluded from the analysis. Higher the percentage of
increase of MSE, the more important the particular gene is for the
prediction of the hepatic TG levels. The genes identified as steatosis-
associated by the network analysis, such as ACOX1, SCD, PPARc, CFD and
CIDEC are also discovered among the top 30 genes resulting from the
regression analysis of gene expression and hepatic TG levels.
doi:10.1371/journal.pone.0006646.g008
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important to note that the late repression of the hepatic NF-kB
driven inflammatory/immune response may not seem in line with
the established model of the obesity-associated inflammation, well
studied in the adipose tissue [10,67]. The previously shown
association of inflammatory signaling pathways with obesity and
hepatic steatosis is the most prominent feature observed in our data.
Nevertheless, the assumption that, similar to the situation in adipose
tissue, hepatic inflammation is secondary to hepatic steatosis is not
supported by our findings [68,69]. In fact, our results show that the
temporal order of events contradicts this assumption, at least during
the examined time frame and in our mouse model. Extending the
duration of treatment and/or increasing amount of excess dietary
fat would likely provoke transitions to further grades of severity in
hepatic pathology such as hepatosteatitis, fibrosis, cirrhosis and
hepatocellular carcinoma. To fully understand the complex
relationship between inflammation and metabolic syndrome,
information originating from different organs and at various time
points needs to be considered on the systems level [69].
Finally, the identified central role of ppar and nemo/nf-kb
regulators in coordinating the onset and progression of metabolic
syndrome may have important implications in treatment of the
disease. currently, pparc ligands are used in clinics for their anti-
inflammatory and insulin-sensitizing effects in diseases such as
psoriasis, atherosclerosis, inflammatory bowel disease and type 2
diabetes [13,14,70–74]. our results suggest that pparc activation
could also have negative effects in disorders where the cross-talk
between inflammation and lipid metabolism is essential to the
development of pathogenesis, as it is in diet-induced metabolic
syndrome. the activation of pparc may inhibit nf-kb and therefore
suppress inflammation, but in turn evoke transition to pathological
state, in this case hepatic steatosis. despite the apparent harmful
effects of inflammation, such as triggering insulin resistance, its
protective physiological role in preventing transitions to even less
preferable system states should not be neglected. thus, the tradeoff
between the beneficial and harmful effects of altered pparc activity
should be carefully considered when using pparc ligands and nf-kb-
inhibiting agents to ameliorate metabolic syndrome associated
pathologies. the presented findings demonstrate the use of high-
throughput dataset analyses as a starting point for generating testable
hypotheses that may open new avenues for dietary prevention
strategies, clinical research and pharmaceutical therapies.
Materials and Methods
Ethics Statement
Animal experiments were approved by the Institutional Animal
Care and Use Committee of the Netherlands Organization for
Applied Scientific Research (TNO) and were in compliance with
European Community specifications regarding the use of labora-
tory animals.
Animals and diets
The study involved 186 male ApolipoproteinE3-Leiden transgen-
ic mice [24] at 1462 weeks of age. Apolipoprotein E3-Leiden
Figure 9. Model of the hepatic physiological response to high-fat diets during the 16-week time-course. The summary of a proposed
model for the hepatic physiological changes in response to high-fat diets during the 16-week time-course in ApoE3L mice. The initial perturbation of
hepatic homeostasis by excess dietary fat triggers the stress response largely controlled by NF-kB and Akt regulators and manifested in activation of
acute phase response, inflammation, immune response, hepatic regeneration-like response and lipotoxicity (day 1 to week 1). Upon prolonged high-
fat feeding, liver fails to regain the basal state and consequently shifts to pathological state controlled by PPAR and SREBP regulators and
characterized by hepatic lipid accumulation and adipogenic transformation, indicative of hepatic steatosis (late phase, week 8 to week 16). The
flagship processes induced at the early and at the late phase are shown in boxes. The transition between the stressed and the pathological hepatic
state may be controlled by trans-inhibitory interactions between NF-kB and PPARc regulators, resulting in the tradeoff between inflammatory and
steatotic transcription programs (mid phase, week 2 to week 4). On the systems level, the activation of steatotic program is followed by other
metabolic syndrome associated pathologies such as obesity and whole-body insulin resistance.
doi:10.1371/journal.pone.0006646.g009
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(ApoE3L) transgenic mice display lipoprotein profile that closely
resembles that of humans and develop human-like dysbetalipopro-
teinemia and atherosclerotic lesions when fed Western-type diets.
The age of 14 weeks was chosen as optimal because the animals are
considered adult at that stage (neither juvenile at early time points
nor aged at the late time points of the study). The first (control) group
of ApoE3L mice was fed standard chow diet (RM3 (E) DU; Special
Diet Services, Witham, Essex, UK), the second group of mice was
fed a high-fat diet based on animal fats (HFBT, beef tallow fat high-
fat diet +0.25% cholesterol, also referred to as Western-type diet,
Arie Blok BV, The Netherlands) and the third group of mice was fed
a high-fat diet based on plant fats (HFP, palm oil high-fat diet based
on open source D12451 SDS diet in which lard is replaced with palm
oil, Research Diet Services, Woerden, The Netherlands). The
macronutrient content and the fatty acid composition of chow and
high-fat diets are provided in Supporting Table S4.
Experimental design and sample preparation
From three weeks prior to diet intervention onwards, all animals
were fed a standard chow diet. At the beginning of the study, mice
were divided into three groups: (1) control group fed chow diet, (2)
group fed HFBT diet and (3) group fed HFP diet. Because the
interest of the study was to asses effects of high-fat diets under
physiological conditions, animals were fed ad libitum. Series of
control experiments employing a metabolic cage setup showed
that C57Bl/6 mice, the genetic background of the APOE3L mice,
have isocaloric food intake when fed low fat and HFBT and HFP
diets. The light cycles were identical for all animals. For mRNA
expression profiling, six mice from each diet group (total n = 150)
were sacrificed at time points 0 days (chow only), 1 day, 3 days, 1,
2, 4, 8, 12 and 16 weeks, their livers were dissected after 4 hour
fasting period (typically from 9 h AM to 1 h PM), snap frozen in
liquid nitrogen and stored at 280uC until further processing.
RNA isolation, labeling and hybridization to microarrays
Total RNA was isolated using TRIzol reagent (Invitrogen, Breda,
The Netherlands) according to the manufacturer’s instructions. RNA
was treated with DNAse and purified using the SV total RNA
isolation system (Promega, Leiden, The Netherlands). Concentrations
and purity of RNA samples were determined on a NanoDrop ND-
1000 spectrophotometer (Isogen, Maarssen, The Netherlands). RNA
integrity was checked on an Agilent 2100 bioanalyzer (Agilent
Technologies, Amsterdam, The Netherlands) with 6000 Nano Chips
according to the manufacturer’s instructions. RNA was considered as
suitable for array hybridization only if samples exhibited intact bands
corresponding to the 18S and 28S ribosomal RNA subunits, displayed
no chromosomal peaks or RNA degradation products, and had a
RNA integrity number (RIN) .8. Applying this criterion, 142 RNA
samples were used for hybridization to microarrays, including 5 to 6
biological replicate samples per diet, per time-point. RNA samples
were hybridized to NuGO Affymetrix Mouse GeneChip arrays
(NuGO_Mm1a520177) containing 23865 probesets including 73
control probesets [26]. Arrays were scanned on a GeneChip Scanner
3000 7G (Affymetrix). Detailed methods for labeling, hybridizations to
the arrays and scanning are described in the eukaryotic section of the
GeneChip Expression Analysis Technical Manual, Revision 3, from
Affymetrix, and are available upon request. The gene expression data
are made available via ArrayExpress repository [75].
Data preprocessing, differential expression analysis and
Gene Set Enrichment Analysis
Quality control of microarray data, normalization, differential
expression analysis and Gene Set Enrichment Analysis [30] were
performed using packages from the R/Bioconductor project
[76,77] through the Management and Analysis Database for
MicroArray eXperiments (MADMAX) analysis pipeline [78].
Quality control of the hybridized microarrays was performed
using simpleaffy and affyplm packages. Upon rigorous examina-
tion of the resulting diagnostic plots, 116 microarrays of the
supreme quality were taken for the further analysis. This resulted
in analysis of 3 to 6 biological replicate samples per diet, per time-
point. Gene expression estimates were calculated using the library
GC-RMA, employing the empirical Bayes approach for back-
ground correction followed by quantile normalization. The
custom MBNI CDF-file (MmNuGOMm1a520177 version 9.0.1),
available at http://brainarray.mbni.med.umich.edu/Brainarray/
Database/CustomCDF/CDF_download_v9.asp and http://nugo-r.
bioinformatics.nl/NuGO_R.html [79,80] was used to re-annotate
the probes to new probesets, remove poor quality probes and derive
unique signal values for different probesets representing the same
gene. This resulted in gene expression values for 15105 genes with
unique identifiers.
Differentially expressed genes between control and each of
treatment groups per time point, as well as between each of time
points and day 0, were identified using the limma package, applying
linear models and moderated t-statistics that implement empirical
Bayes regularization of standard errors [27]. False discovery rate of
10% (q-value,0.1) was used as a threshold for significance of
differential expression. Significance of the overlap between
differentially expressed genes in HFBT and HFP conditions
(Figure 1B) was calculated by hypergeometric distribution.
The t-test values of differential expression between control and
each of treatment groups per time point calculated using limma
package were used as the input for the PreRanked scoring method
within the Gene Set Enrichment Analysis (GSEA). Gene sets
collection included 880 gene sets compiled from MSigDB C2,
Biocarta, Kyoto Encyclopedia of Genes and Genomes (KEGG)
and GenMAPP databases as well as the expert curated gene sets.
Detailed information about gene sets used for GSEA analysis,
including source websites is available upon request. Gene set size
filter (min= 15, max= 500) resulted in filtering out 405 of 880
gene sets. The number of permutations for was set to 1000. Gene
sets are considered significantly enriched at false discovery rate
(FDR) smaller than 10% (q-value,0.1). In total, 314 gene sets are
identified as significantly enriched in at least 1 of 16 comparisons
(HFBT vs. chow and HFP vs. chow per time-point). Normalized
enrichment scores (NES) of significantly enriched pathways and
the corresponding FDR q-values across all experimental condi-
tions are available upon request.
Hierarchical clustering and data visualization
Hierarchical clustering and visualization of gene expression
changes in Figures 1C, 2 and 6 were performed in GeneSpring
GX 7.3.1 software (Agilent), using average gene expression values
under HFBT and HFP conditions divided by the median of chow
gene expression, per time-point. Hierarchical clustering and
visualization of NES values in Figure 3 were performed using
HierarchicalClusteringViewer and HeatmapViewer modules with-
in the GenePattern analysis suite [81–83].
Analysis of gene expression profiles of HF-responsive
genes
Temporal analysis of the gene expression profiles where each of HF
groups is compared to chow per time point (Figure S2, S3, S4 and S5)
was performed using Smoothing Spline Clustering algorithm [28]
through the R computing environment [76], applying the settings
nchain=5 and nclust=24. Setting the number of clusters to 24 yielded
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Bayesian information criterion (BIC) values that were at the bottom of
the U-shaped BIC curve (i.e. closely approaching the optimum), while
resulting in images of reasonable complexity. As input values, average
log2 ratios of 1663 high-fat responsive genes were used (HFBT and
HFP divided by median of chow per time point). To facilitate
visualization of temporal trends, the starting time point (t =0, only
chow fed mice) was also included in the analysis.
Overrepresentation analysis of functional categories
Identification of overrepresented functional categories among
1663 high-fat responsive genes and their grouping into function-
ally related clusters was performed using DAVID Functional
Annotation Clustering tool [29]. The analysis was performed using
Gene Ontology, Protein domains, Pathways and Functional
categories according to the default settings (Table S3, version
date July 2007). Representative functional categories from the
most statistically significant clusters are manually selected and
listed in Figure 2. Equivalent analysis is performed using separately
upregulated (922 genes) and downregulated (786 genes) high-fat
responsive genes (Table S3, version date June 2009).
Network analysis
The network analysis was generated through the use of Ingenuity
Pathways Analysis (version date March 2008) [31]. The data set
containing gene identifiers and corresponding expression values for
1663 high-fat responsive genes was uploaded into the application.
Of 1663 gene identifiers, 1660 were successfully mapped to its
corresponding gene objects in the Ingenuity Pathways Knowledge
Base and 1303 were identified as network eligible. These genes were
overlaid onto a global molecular network developed from
information contained in the Ingenuity Pathways Knowledge Base.
Networks were then algorithmically generated and graphically
represented based on connectivity of genes. The Functional Analysis
of the network identified the biological functions and/or diseases
that were most significant to the genes in the network (version date
June 2009). Fischer’s exact test was used to calculate a p-value
determining the probability that each biological function and/or
disease assigned to that network is due to chance alone. Genes or
gene products are represented as nodes, and the biological
relationship between two nodes is represented as an edge (line).
The node color indicates up- (red) or down- (green) regulation. The
direction of average expression changes in HFBT vs. chow
comparisons (Table S2) at day 3 and week 12 was used for color
coding in Figure 4 and Figure 5, respectively.
Accession numbers
For the microarray experiments described in this study,
MIAME compliant protocols and datasets in Tab2MAGE are
accessible from ArrayExpress microarray data repository [75] with
the accession number E-TABM-553.
Plasma proteins and hepatic triglyceride content analysis
Plasma proteins were quantified by multiplex immunoassay
measurements at Rules Based Medicine (Rules Based Medicine,
Inc., Austin, Texas, USA). Plasma antigens immunoassay panel
included in the Rodent Multi-Analyte Profile was used for
measurement of expression levels of 58 proteins (RodentMAP
version 2 antigen panel). Of these, 47 proteins had sufficient
detectability of the expression signals and were included in the
further analysis. Statistical significance of protein expression in
HFBT andHFP fed mice compared to chow fed mice per time-point
(marked with asterisk and hash symbol, respectively) was assessed by
t-test. The p value of 0.05 was used as a threshold for significance.
Liver lipid content was defined as total triglyceride content (mmol)
per mg of protein. Extraction was performed using a modified Bligh
and Dyer extraction protocol, optimized for steatotic liver material.
Triglyceride content was measured enzymatically using the Roche
TG kit (Roche, cat. No. 11488872216). Protein content was
measured by BCA analysis (BCA protein Assay Kit, Pierce, cat.
No. 23225). Statistical significance of hepatic triglyceride content in
HFBT and HFP fed mice compared to chow fed mice per time-point
(marked with asterisk and hash symbol, respectively) was assessed by
t-test. The p value of 0.01 was used as a threshold for significance.
Regression analysis of gene expression and hepatic
triglyceride content
To determine the relation between gene expression data and
triglyceride levels in the liver tissue, Random Forests regression
was used through randomForest package of R statistical
computing environment [48,49,76,84]. The gene expression
values of 1663 high-fat responsive genes and the hepatic
triglyceride levels of the matching animals at each time-point
were used as an input for the analysis. In Random Forests
regression, a group of regression trees is used for the model. In
every individual regression tree, the data are split at each node
until all objects are in a single leaf. For each tree only a subset of
the data is used and at each node only a subset of the variables is
used to make the split. By intentionally incorporating only part of
the data for each tree, the data which are not used to generate the
tree can be used to assess its performance. The term used for this
measure is the Out Of Box (OOB) error. Besides the OOB
measure for the overall model, it is possible to asses the importance
of individual variables in the model. Here we used the increase of
Mean Squared Error (MSE). The Mean Squared Error is a
general measure for the overall fit of a model and its increase
measures the importance of individual variables (in this case genes)
when they are excluded from the analyses. The higher the increase
of the MSE when a gene is excluded from the analysis, the more
important that particular gene is for the fit of the model (and for
the prediction of triglyceride levels in liver). The MSE of the
Random Forests regression model presented here is 49.9 percent.
The top 30 genes that have the highest increase of MSE and
therefore provide best prediction of triglyceride levels are shown in
Figure 8B. The term prediction is used here to refer to the ability
to predict the triglyceride levels as they were measured on the basis
of gene expression, rather than in the sense of prognostic for the
future progress of steatosis in time.
Random Forests is an improved Classification and Regression
Trees (CART) method. It grows many classification trees or
regression trees, hence the name ‘Forests’. For quantitative
outcomes the forest is made of regression trees, where the tree
predictor is the mean value of the training set observations in each
terminal leaf. In our application of random forests the outcomes are
quantitative, therefore the regression algorithm and not classifica-
tion was used. Every tree is built using a deterministic algorithm and
the trees are different owing to two factors. First, at each node, a best
split is chosen from a random subset of the predictors rather than all
of them. Second, every tree is built using a bootstrap sample of the
observations. The out-of-bag (OOB) data, one-third of the
observations, are then used to estimate the prediction accuracy.
Unlike other tree algorithms, no pruning, trimming of the fully
grown tree, is involved. Each observation is assigned to a leaf, the
terminal node of a tree, according to the order and values of the
predictor variables. For a particular tree, the predictions for
observations are given only for the OOB data. The Random Forest
predictor is computed by averaging the tree predictors over trees for
which the given observation was OOB. Because the prediction for
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an observation is based on trees grown without the observation, an
idea akin to cross-validation, the estimated errors are unbiased and
the data were not divided in test and training sets.
Supporting Information
Figure S1 Temporal changes in gene expression for HFBT,
HFP and chow diet over the 16-week period compared to day 0.
The number of statistically significant differentially expressed
genes (DEG) identified by pairwise comparison of each time-point
versus day 0 (limma, FDR,0.1) in chow, HFBT and HFP dietary
conditions. Venn diagram shows overlap of total (in any of time
points) number of DEGs in the three diets.
Found at: doi:10.1371/journal.pone.0006646.s001 (0.37 MB
PDF)
Figure S2 Temporal gene expression profiles (HFBT, raw
curves). The results of Smoothing Spline Clustering analysis [25]
for 1663 high-fat responsive genes. The genes are grouped into 24
clusters according to their temporal expression profiles. The
vertical axis represents the expression ratios and the horizontal
axis the time points 1 to 9 (day 0, day 1, day 3, week 1, week 2,
week 4, week 8, week 12 and week 16). Figure S2 corresponds to
the HFBT experimental conditions and raw expression ratio
values.
Found at: doi:10.1371/journal.pone.0006646.s002 (0.07 MB
PDF)
Figure S3 Temporal gene expression profiles (HFBT, mean
curves). The results of Smoothing Spline Clustering analysis [25]
for 1663 high-fat responsive genes. The genes are grouped into 24
clusters according to their temporal expression profiles. The
vertical axis represents the expression ratios and the horizontal
axis the time points 1 to 9 (day 0, day 1, day 3, week 1, week 2,
week 4, week 8, week 12 and week 16). Figure S3 corresponds to
the HFBT experimental conditions and mean expression ratio
values (and their confidence intervals, in red) of the genes in each
cluster.
Found at: doi:10.1371/journal.pone.0006646.s003 (0.02 MB
PDF)
Figure S4 Temporal gene expression profiles (HFP, raw curves).
The results of Smoothing Spline Clustering analysis [25] for 1663
high-fat responsive genes. The genes are grouped into 24 clusters
according to their temporal expression profiles. The vertical axis
represents the expression ratios and the horizontal axis the time
points 1 to 9 (day 0, day 1, day 3, week 1, week 2, week 4, week 8,
week 12 and week 16). Figure S4 corresponds to the HFP
experimental conditions and raw expression ratio values.
Found at: doi:10.1371/journal.pone.0006646.s004 (0.07 MB
PDF)
Figure S5 Temporal gene expression profiles (HFP, mean
curves). The results of Smoothing Spline Clustering analysis [25]
for 1663 high-fat responsive genes. The genes are grouped into 24
clusters according to their temporal expression profiles. The
vertical axis represents the expression ratios and the horizontal
axis the time points 1 to 9 (day 0, day 1, day 3, week 1, week 2,
week 4, week 8, week 12 and week 16). Figure S5 corresponds to
the HFP experimental conditions and mean expression ratio
values (and their confidence intervals, in red) of the genes in each
cluster.
Found at: doi:10.1371/journal.pone.0006646.s005 (0.02 MB
PDF)
Table S1 Detailed overview of numbers of differentially
expressed genes in HFBT vs. chow and HFP vs. chow
comparisons (limma, FDR,0.1). The information summarized
in Table 1 is extended to a detail to include: (1) number of
upregulated genes per diet and time point, (2) number of
downregulated genes per diet and time point, (3) total (both up-
and downregulated) number of differentially expressed genes per
diet and time point, (4) number of overlapping genes between
HFBT and HFP diets for each of categories (1)–(3), (5) number of
genes in union of HFBT and HFP diets for each of categories (1)–
(3) and (6) total (in all time-points) number of differentially
expressed genes for categories (1)–(5).
Found at: doi:10.1371/journal.pone.0006646.s006 (0.05 MB
DOC)
Table S2 Annotation and statistics for 1663 high-fat responsive
genes. The list of 1663 genes differentially expressed under the
high-fat conditions (false discovery rate q-value,0.1 in either of
HFBT versus chow and HFP versus chow comparisons per time-
point), including detailed annotation of these genes, expression
ratios and the statistics (as determined by limma package) in each
of the experimental conditions.
Found at: doi:10.1371/journal.pone.0006646.s007 (3.10 MB
XLS)
Table S3 Overrepresentation analysis of functional categories
among all, upregulated and downregulated HF-responsive genes.
The complete results of functional categories overrepresentation
analyses and their grouping into functionally related clusters generated
using DAVID Functional Annotation Clustering tool [29]. The
analyses were performed using (1) all (n=1663), (2) upregulated
(n=922) and (3) downregulated (n=786) high-fat responsive genes.
Found at: doi:10.1371/journal.pone.0006646.s008 (1.89 MB
XLS)
Table S4 The macronutrient content and the fatty acid
composition of chow and high-fat diets. The macronutrient
content and the fatty acid composition of chow, HFBT and
HFP diets.
Found at: doi:10.1371/journal.pone.0006646.s009 (0.04 MB
DOC)
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